Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Univest Financial
UVSP
$1.22B
| $167K | ﹤0.01% |
9,619
-11,690
| -55% | -$215K |
|
3577
Blink Charging
BLNK
$70.4M
| $167K | ﹤0.01% |
54,573
-15,201
| -22% | -$76.5K |
|
3578
State Street SPDR S&P International Small Cap ETF
GWX
$862M
| $167K | ﹤0.01% |
5,726
-1,947
| -25% | -$59.5K |
|
|
LNW
3579
DELISTED
Light & Wonder
LNW
| $167K | ﹤0.01% |
2,338
-121,342
| -98% | -$8.8M |
|
3580
Transcat
TRNS
$778M
| $166K | ﹤0.01% |
1,691
-698
| -29% | -$66.7K |
|
3581
Schwab International Equity ETF
SCHF
$67B
| $165K | ﹤0.01% |
9,712
+1,494
| +18% | +$26.4K |
|
3582
Golar LNG
GLNG
$4.91B
| $165K | ﹤0.01% |
6,782
-26,771
| -80% | -$617K |
|
3583
Horizon Bancorp
HBNC
$1.05B
| $164K | ﹤0.01% |
15,392
-34,982
| -69% | -$393K |
|
|
NINE
3584
DELISTED
Nine Energy Service
NINE
| $164K | ﹤0.01% |
+39,898
| New | +$180K |
|
|
APLT
3585
DELISTED
Applied Therapeutics
APLT
| $164K | ﹤0.01% |
+65,976
| New | +$109K |
|
3586
Gossamer Bio
GOSS
$87.2M
| $164K | ﹤0.01% |
196,732
+194,768
| +9,917% | +$224K |
|
|
TPIC
3587
DELISTED
TPI Composites
TPIC
| $164K | ﹤0.01% |
61,768
-18,596
| -23% | -$114K |
|
|
FYBR
3588
DELISTED
Frontier Communications
FYBR
| $163K | ﹤0.01% |
10,390
-5,821
| -36% | -$94.5K |
|
3589
Atlas Energy Solutions
AESI
$1.29B
| $162K | ﹤0.01% |
7,299
-4,901
| -40% | -$103K |
|
3590
iShares US Healthcare Providers ETF
IHF
$1.21B
| $162K | ﹤0.01% |
3,290
| – | – |
|
3591
Carter's
CRI
$1.39B
| $162K | ﹤0.01% |
2,339
-3,960
| -63% | -$283K |
|
3592
International Seaways
INSW
$4.71B
| $161K | ﹤0.01% |
3,585
-18,427
| -84% | -$773K |
|
3593
Expensify
EXFY
$178M
| $161K | ﹤0.01% |
49,589
+32,279
| +186% | +$174K |
|
3594
Acumen Pharmaceuticals
ABOS
$157M
| $160K | ﹤0.01% |
38,498
+37,801
| +5,423% | +$234K |
|
3595
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.4B
| $160K | ﹤0.01% |
+2,449
| New | +$165K |
|
3596
Invesco Dorsey Wright Momentum ETF
PDP
$1.45B
| $158K | ﹤0.01% |
2,056
-3
| -0.1% | -$239 |
|
3597
PUT
Intellia Therapeutics
NTLA
$1.55B
| $158K | ﹤0.01% |
+5,000
| New | +$194K |
|
3598
iShares Global Financials ETF
IXG
$679M
| $158K | ﹤0.01% |
2,239
-30
| -1% | -$2.17K |
|
3599
Sabesp
SBS
$19.2B
| $157K | ﹤0.01% |
66,896
+4,069
| +6% | +$9.24K |
|
3600
Lineage Cell Therapeutics
LCTX
$277M
| $157K | ﹤0.01% |
133,051
-25,720
| -16% | -$35K |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.